Description
CNP-TMZ, or Temozolomide encapsulated in Carbon Nano Particles, is an advanced drug delivery system aimed at enhancing the therapeutic potential of temozolomide, a key chemotherapeutic agent. Encapsulation in carbon nanoparticles boosts the drug’s stability, bioavailability, and targeted delivery to tumor cells, potentially improving treatment outcomes in cancer therapies. By reducing systemic toxicity and providing controlled drug release, CNP-TMZ offers a more efficient and patient-friendly approach for managing cancer, particularly in difficult-to-treat cases like brain tumors.
